Abstract

Because proteases free in the body are damaging to the tissues, animals have evolved various agents for their inactivation and clearance. Mammals, for instance, have a diverse array of active site protease inhibitors in the plasma. In addition, mammals have alpha 2-macroglobulin (alpha 2M), which binds active proteases, and the alpha 2M-protease complex is then cleared from the plasma by a receptor-mediated endocytotic process. alpha 2M is also present in the plasma of many invertebrates, and in the American horseshoe crab, Limulus polyphemus, it is the only protease inhibitor in the plasma. To search for a clearance process for proteases in Limulus, fluorescein isothiocyanate (FITC)-labeled proteins were injected into the blood, and the fluorescence in the plasma and associated with the blood cells was determined. FITC-labeled trypsin was cleared with an initial mixing period (0-10 min) and a rapid clearance period (10-30 min), followed by the reappearance of FITC in the plasma (45-90 min). Before and during the clearance process, the labeled trypsin was associated with a complex having a molecular mass identical to that of Limulus alpha 2M, and that was precipitated by antibodies directed against Limulus alpha 2M. The fluoresceinated material that reappeared in the plasma after 45 min was of low molecular mass (< 10 kDa) and thus appears to have experienced degradation. The clearance of trypsin requires its protease activity, since phenylmethylsulfonyl fluoride-inactivated, FITC-labeled trypsin was cleared only very slowly if at all (t1/2 > 180 min). FITC-labeled, trypsin-reacted Limulus alpha 2M was cleared rapidly from the plasma of Limulus, whereas FITC-labeled, native Limulus alpha 2M persisted undiminished in excess of 400 min. The blood cells of Limulus bound FITC-labeled trypsin-reacted Limulus alpha 2M, and the peak of recovery from the blood cells coincided with the minimum concentration of FITC-labeled protein in the plasma, suggesting that the blood cells participate in the clearance of alpha 2M-protease complex from the plasma. Thus, we have demonstrated the existence of a clearance pathway in Limulus that operates selectively on enzymatically active proteases and have shown that Limulus alpha 2M is the probable agent for protease clearance. This is the first documentation of a protease clearance pathway in invertebrates and represents the first identified physicological function for alpha 2M in invertebrates.

Highlights

  • In marked contrast to the active site inhibitors, uzM-bound proteases retain the enzymatic activity of the active site and can still hydrolyze amide or ester substrates small enough to diffuse into the uzM cage (Bieth et aZ., 1978; Beatty et aZ., 1982; Berthillier et aZ., 1968)

  • Protease binding begins with the proteolytic cleavage of the uzM polypeptide at a region known as the ''bait'' region (Barrett and Starkey, 1973; Barrett et aZ., 1979; Hall and Roberts, 1978; Sottrup-Jensen et aZ., 1981) and is immediately followed by a physical folding of uzM around the target protease to "trap" it within the uzM cage (Barrett et aZ., 1979; Cummings et aZ., 1984; Nelles et aZ., 1980; Hall and Roberts, 1978)

  • The binding of uzM to endopeptidases is followed by the clearance of the O!zM-protease complex from the circulation by hepatocytes

Read more

Summary

Introduction

The active site inhibitors bind to and inactivate the active sites of target proteases (Laskowski and Kato, 1980; Travis and Salvesen, 1983), whereas uzM enfolds the target protease molecule in a molecular cage that shields it from protein substrates (Sottrup-Jensen, 1987; Barrett and Starkey, 1973; Barrett, 1981). The binding of uzM to endopeptidases is followed by the clearance of the O!zM-protease complex from the circulation by hepatocytes In contrast to other protease inhibitors that bind to the active site of the protease resulting in immediate enzymatic inactivation, the receptor-mediated endocytotic clearance of Q!2M-protease complex from the circulation must be regarded as part of its inactivation mechanism

Objectives
Methods
Results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.